NO129299B - - Google Patents

Download PDF

Info

Publication number
NO129299B
NO129299B NO169877A NO16987767A NO129299B NO 129299 B NO129299 B NO 129299B NO 169877 A NO169877 A NO 169877A NO 16987767 A NO16987767 A NO 16987767A NO 129299 B NO129299 B NO 129299B
Authority
NO
Norway
Prior art keywords
androstane
oxo
methyl
general formula
pregnane series
Prior art date
Application number
NO169877A
Other languages
Norwegian (no)
Inventor
O H Sjoeberg
B A Ekstroem
Original Assignee
Beecham Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB26488/61A external-priority patent/GB940488A/en
Priority claimed from GB26489/61A external-priority patent/GB940489A/en
Priority claimed from NO14502962A external-priority patent/NO124690B/no
Application filed by Beecham Group Ltd filed Critical Beecham Group Ltd
Priority to NO169877A priority Critical patent/NO129299B/no
Publication of NO129299B publication Critical patent/NO129299B/no

Links

Landscapes

  • Steroid Compounds (AREA)

Description

Fremgangsmåte til fremstilling av terapeutisk virksomme 6a-metyl-3-oxo-A<4->steroider av androstan og pregnanrekkene. Process for the production of therapeutically effective 6a-methyl-3-oxo-A<4->steroids from the androstane and pregnane series.

Foreliggende oppfinnelse angår en fremgangsmåte til fremstilling av 6a-metyl-3-oxo-A<4->steroider av androstan- og pregnan The present invention relates to a process for the production of 6a-methyl-3-oxo-A<4->steroids from androstane and pregnane

-rekkene. - the ranks.

Ved hjelp av fremgangsmåten ifølge Using the method according to

oppfinnelsen kan der fremstilles nye for-bindelser av androstan- og pregnanrekkene som er verdifulle på grunn av deres biologiske egenskaper (f. eks. som anaboliske eller progestasjonale midler) eller som mel-lomprodukter ved fremstilling av forbin-delser med verdifulle biologiske egenskaper. the invention, new compounds of the androstane and pregnane series can be produced which are valuable because of their biological properties (e.g. as anabolic or progestational agents) or as intermediate products in the production of compounds with valuable biological properties.

Et vesentlig karakteristisk trekk ved fremgangsmåten ifølge oppfinnelsen til fremstilling av 6a-metyl-3-oxo-A<4->steroider av androstan- og pregnanrekkene med den generelle formel: A significant characteristic feature of the process according to the invention for the production of 6a-methyl-3-oxo-A<4->steroids of the androstane and pregnane series with the general formula:

i hvilken X betegner en av gruppene I eller in which X denotes one of the groups I or

er at man be- is that one beg-

i in

handler et 3(3 : 5a-dihydroxy-6(3-metylste-roider av androstan- og pregnanrekkene med den generelle formel: is a 3(3:5a-dihydroxy-6(3-methylsteroid of the androstane and pregnane series) with the general formula:

(hvor X har den ovenfor angitte betydning) (where X has the above meaning)

med et aluminiumalkoholat i en blanding av cykloheksanon og toluen under opp-varming med tilbakeløpskjøling. Når man f. eks. bruker aluminium-tertiært-butoxyd i en blanding av cykloheksanon og toluen (dvs. Oppenauers oxydasjonsmiddel), og with an aluminum alcoholate in a mixture of cyclohexanone and toluene under reflux heating. When you e.g. uses aluminum tertiary butoxide in a mixture of cyclohexanone and toluene (i.e., Oppenauer's oxidizing agent), and

oppvarmer under tilbakeløpskjøling, inn-treffer oxydasjonen i 3-stillingen sammen med avvanning av hydroxyl-gruppen i 5a-stillingen, så at man får et 6|3-metyl-3-oxo-A<4->steroid, som undergår epimeriser-ing ved kullstoffatomet i 6-stillingen, så at man får 6a-metyl-3-oxo-A<4->steroidet. heated under reflux, the oxidation occurs in the 3-position together with dehydration of the hydroxyl group in the 5a-position, so that a 6|3-methyl-3-oxo-A<4->steroid is obtained, which undergoes epimerization ing at the carbon atom in the 6-position, so that you get the 6a-methyl-3-oxo-A<4->steroid.

I det følgende beskrive^ som eksempel en utførelsesform for fremgangsmåten ifølge oppfinnelsen. In the following, an embodiment of the method according to the invention is described as an example.

Eksempel. Example.

17|3-hydroxy-6a : 17a-dimetylandrost-4-en-3-on. 17|3-hydroxy-6a : 17a-dimethylandrost-4-en-3-one.

En oppløsning av 6(3 : 17a-dimetyl-androstan-3|3 : 5a : 17|3-triol (1,2 g) i cykloheksanon (8,2 ml) ble tilsatt til en opp-løsning av aluminium-tertiært-butoxyd To a solution of aluminum tertiary- butoxide

(1,1 g) i toluen (5 ml) og blandingen ble (1.1 g) in toluene (5 ml) and the mixture was

oppvarmet under tilbakeløpskjøling i 45 heated under reflux for 45

minutter. Benzen (ca. 50 ml) ble tilsatt og minutes. Benzene (about 50 ml) was added and

oppløsningen vasket med fortynnet svovel-syre og vann. Oppløsningen ble derpå des-tillert med damp i 4 timer, hvorpå den ble the solution washed with dilute sulfuric acid and water. The solution was then distilled with steam for 4 hours, after which it became

ekstrahert med eter. Ekstraktet ble vasket extracted with ether. The extract was washed

med vann, tørket og inndampet. Man lot with water, dried and evaporated. Man pretended

residuet i benzen gå gjennom en alumini-umoxydsøyle (10 g) og det resulterende the residue in benzene pass through an aluminum oxide column (10 g) and the resulting

oljeaktige produkt ble krystallisert fra en oily product was crystallized from a

blanding av aceton og heksan. Herved skilte mixture of acetone and hexane. Hereby signed

17(3-hydroxy-6a : 17a - dimetylandrost-4-en-3-on (6a-dimetyltestosteron) seg ut 17(3-hydroxy-6a : 17a - dimethylandrost-4-en-3-one (6a-dimethyltestosterone)

i form av nåler. Sm.p. 134—135° C. in the form of needles. Sm.p. 134-135° C.

23° 23°

[a] D = + 49° (c, 0,421 i etanol), [a] D = + 49° (c, 0.421 in ethanol),

l maks. m\ i (4,19) i isopropanol. l max. m\ in (4.19) in isopropanol.

Claims (1)

1. Fremgangsmåte til fremstilling av1. Method for the production of terapeutisk virksomme 6a-metyl-3-oxo-A<4 >steroider av androstan- og pregnanrekkene med den generelle formel: li hvilken X betegner en av gruppene karakterisert ved at man behandler et 3(5 : 5a-dihydroxy-6p-metylsteroid av androstan- og pregnanrekkene med den generelle formel: (hvor X har den ovenfor angitte betydning) med et aluminiumalkoholat i en blanding av cykloheksanon og toluen under oppvar-ming med tilbakeløpskjøling.therapeutically effective 6a-methyl-3-oxo-A<4 >steroids of the androstane and pregnane series with the general formula: li which X denotes one of the groups characterized by treating a 3(5 : 5a-dihydroxy-6p-methylsteroid of the androstane and pregnane series with the general formula: (where X has the meaning given above) with an aluminum alcoholate in a mixture of cyclohexanone and toluene under heating with reflux cooling.
NO169877A 1961-07-21 1967-09-26 NO129299B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO169877A NO129299B (en) 1961-07-21 1967-09-26

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB26488/61A GB940488A (en) 1961-07-21 1961-07-21 Penicillins
GB26489/61A GB940489A (en) 1961-07-21 1961-07-21 Penicillins
NO14502962A NO124690B (en) 1961-07-21 1962-07-06
NO169877A NO129299B (en) 1961-07-21 1967-09-26

Publications (1)

Publication Number Publication Date
NO129299B true NO129299B (en) 1974-03-25

Family

ID=27448690

Family Applications (1)

Application Number Title Priority Date Filing Date
NO169877A NO129299B (en) 1961-07-21 1967-09-26

Country Status (1)

Country Link
NO (1) NO129299B (en)

Similar Documents

Publication Publication Date Title
US2648662A (en) Preparation of 3, 20-diketo-17alpha-hydroxy steroids
NO129299B (en)
US2802839A (en) Preparation of 3-ketopregnenes
US2863862A (en) 1-methyl steroid derivatives and method for the production thereof
NO121103B (en)
US2835680A (en) delta8(9)-steroids and their process of preparation
US3043832A (en) Preparation of 6alpha-methyl-17alpha-hydroxyprogesterone and 17alpha-esters thereof
US3040035A (en) 17alpha-acyloxy-6alpha-methyl-16-methylenepregn-4-ene-3, 20-diones and process and intermediates for the preparation thereof
US2847429A (en) Process for the preparation of 3-enol lower alkanoyl acylates of 17beta-acyloxy delta-androstene-3-one
US3158629A (en) 6alpha, 16alpha-dimethyl-delta4-pregnen-17alpha-ol-3, 20-dione-17-acylates
US3067196A (en) Process for the preparation of steroids substituted in the 12-position and products resulting therefrom
AT232658B (en) Process for the preparation of new steroids unsaturated in the 1- and 4-positions
US3084173A (en) Ethinyl and vinyl derivatives of 19-norandrostan-3beta, 17beta-diol
US3078285A (en) 12-alkyl steroids of the pregnane series
US2372841A (en) Process for the manufacture of polynuclear carbonyl compounds and their enol esters
AT241705B (en) Process for the production of new, unsaturated halogen steroids
US2813884A (en) 4-pregnenes and method of preparing the same
US2926181A (en) 17-alpha, 21-diol-3, 20 diketo-4, 6-pregnedienes and a process for their production
US3082219A (en) Method for the preparation of delta16-20-keto steroids
US3213085A (en) 19-lower alkyl-delta4-pregnen-20-one derivatives
US3147250A (en) Process for preparing 11-oximino-delta5-steroids and products thereof
US3055919A (en) 17alpha-(lower alkanoyl)oxy-2-halopregna-4, 6-diene-3, 20-diones
US2937191A (en) Process for the production of delta9(11) steroids
US3158605A (en) 2, 19-cyclo-derivatives of cortical hormones
AT239455B (en) Process for the preparation of new 17α-acyloxy-6-methyl-16-methylenpregna-4,6-diene-3,20-diones